 |
|
|
| |
A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide in Children and Adolescent Patients With Chronic Hepatitis B
|
| |
| |
EASL 2022 June 22-26 London
Kathleen B. Schwarz,1 Jorge Bezerra,2 Byung-Ho Choe,3 Chuan-Hao Lin,4 Frida Abramov,5 Anh-Hoa Nguyen,5 Yang Liu,5 Rory Leisegang,5 John F. Flaherty,5 Daniela Pacurar,6 Kyung Mo Kim,7 Ilsiyar Khaertynova,8 Shalimar,9 Jia-Feng Wu,10 Manish Tandon,11 Philip Rosenthal,12 Viacheslav Morozov,13 Etienne Sokal,14 Mei-Hwei Chang15
1UC San Diego School of Medicine, La Jolla, and Rady Children's Hospital-San Diego, California, USA; 2University of Cincinnati, Cincinnati Children's Hospital Medical Center, Ohio, USA; 3Kyungpook National University College of Medicine, Daegu, Republic of Korea; 4Children's Hospital Los Angeles, California; 5Gilead Sciences, Inc., Foster City, California; 6Universitatea de Medicina si Farmacie "Carol Davila" din Bucuresti, Spitalul Clinic de Urgenta pentru Copii "Grigore Alexandrescu," Bucuresti, Romania; 7University of Ulsan College of Medicine,
Asan Medical Center Children's Hospital, Seoul, Republic of Korea; 8Kazan State Medical University, Kazan, Russian Federation; 9All India Institute of Medical Sciences, New Delhi, India; 10National Taiwan University Hospital, Taipei City, Taiwan; 11M. V. Hospital and Research Centre, Lucknow, India; 12University of California San Francisco; 13Hepatolog, Samara, Russian Federation; 14Université Catholique de Louvain, Louvain-la-Neuve, and Cliniques Universitaires Saint-Luc, Bruxelles, Belgique; 15National Taiwan University Children's Hospital, Taipei City
|
| |
|
|
|
|
|
